Literature DB >> 16582096

Stable isotope methods for the in vivo measurement of lipogenesis and triglyceride metabolism.

E J Murphy1.   

Abstract

Synthesis of fatty acids (via de novo lipogenesis) and triglycerides are important factors in fat accumulation and the efficiency of animal production. Recently, new stable isotope methods using heavy water (2H2O) have made possible the safe, and relatively easy, measurement of both of these processes in vivo in animals and humans over prolonged periods. These methods also provide information on the relative contribution of glycolysis and glyceroneogenesis to triglyceride synthesis under different physiological settings. The data suggest that numerous dietary factors, including nutrient composition and caloric content, may affect de novo lipogenesis. Significant differences in de novo lipogenesis have also been seen across species and in different tissues. The rates of triglyceride synthesis have been shown to be affected by diet and to differ significantly between different adipose depots, with metabolically active depots (e.g., visceral fat) having much more rapid triglyceride turnover than subcutaneous depots. Dietary fat and the peroxisome proliferator-activated-gamma agonist rosiglitazone have both been shown to influence triglyceride synthesis rates and to increase glyceroneogenesis. A significant portion of triglyceride synthesis is not related to triglyceride accumulation but rather is secondary to active lipolysis and reesterification. The application of these new techniques to animals other than rodents will undoubtedly enhance our understanding of adipose tissue biology and could lead to new methods for improving animal production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582096     DOI: 10.2527/2006.8413_supple94x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  16 in total

Review 1.  (13)C-Breath testing in animals: theory, applications, and future directions.

Authors:  Marshall D McCue; Kenneth C Welch
Journal:  J Comp Physiol B       Date:  2015-12-11       Impact factor: 2.200

Review 2.  Fructose-containing sugars and cardiovascular disease.

Authors:  James M Rippe; Theodore J Angelopoulos
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

3.  A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice.

Authors:  Joao A G Duarte; Filipa Carvalho; Mackenzie Pearson; Jay D Horton; Jeffrey D Browning; John G Jones; Shawn C Burgess
Journal:  J Lipid Res       Date:  2014-09-30       Impact factor: 5.922

4.  The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species.

Authors:  David G McLaren; Timothy He; Sheng-Ping Wang; Vivienne Mendoza; Raymond Rosa; Karen Gagen; Gowri Bhat; Kithsiri Herath; Paul L Miller; Sloan Stribling; Andrew Taggart; Jason Imbriglio; Jinqi Liu; Dunlu Chen; Shirly Pinto; James M Balkovec; Robert J Devita; Donald J Marsh; Jose M Castro-Perez; Alison Strack; Douglas G Johns; Stephen F Previs; Brian K Hubbard; Thomas P Roddy
Journal:  J Lipid Res       Date:  2011-03-17       Impact factor: 5.922

5.  Polyphenols and cholesterol efflux: is coffee the next red wine?

Authors:  Megan F Burke; Amit V Khera; Daniel J Rader
Journal:  Circ Res       Date:  2010-03-05       Impact factor: 17.367

6.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

7.  Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.

Authors:  Joseph J Lee; Jennifer E Lambert; Yelena Hovhannisyan; Maria A Ramos-Roman; Justin R Trombold; David A Wagner; Elizabeth J Parks
Journal:  Am J Clin Nutr       Date:  2014-11-19       Impact factor: 7.045

8.  Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes.

Authors:  D J Baker; G P Wilkinson; A M Atkinson; H B Jones; M Coghlan; A D Charles; B Leighton
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 9.  Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans.

Authors:  John L Sievenpiper; Amanda J Carleton; Sheena Chatha; Henry Y Jiang; Russell J de Souza; Joseph Beyene; Cyril W C Kendall; David J A Jenkins
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 17.152

10.  Technical Note: In vivo estimation of lipogenesis using a bolus injection of [U-13C]glucose in pigs.

Authors:  Hector H Salgado; Aline Remus; Candido Pomar; Marie-Pierre Létourneau-Montminy; Hélène Lapierre
Journal:  J Anim Sci       Date:  2021-06-01       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.